Results 41 to 50 of about 12,655 (161)

Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3

Clinical and Translational Science, 2022
Residual shallow neuromuscular block (NMB) is potentially harmful and contributes to critical respiratory events. Evidence for the optimal dose of sugammadex required to reverse vecuronium‐induced shallow NMB is scarce. The aims of the present study were
Jing He, Huan He, Xing Li, Mei Sun, Zhihao Lai, Bo Xu   +5 more
doaj   +1 more source

Effects of Sugammadex and Neostigmine on Post-operative Nausea and Vomiting in ENT Surgery

Frontiers in Medicine, 2022
We aim to compare the effects of sugammadex on postoperative nausea and vomiting (PONV) with those of neostigmine–atropine mixture. A total of 136 American Society of Anesthesiology (ASA) I or II patients, aged 18 to 65 years who underwent ear, nose, and
Nik Izyan Syaizana Nik Mat, Chih Nie Yeoh, Muhammad Maaya, Jaafar Md Zain, Joanna Su Min Ooi   +4 more
doaj   +1 more source

Real‐World Impact on Postoperative Vomiting by Changing Anesthesia Regimens in Children Undergoing Strabismus Surgery: An Interrupted Time Series Analysis

Pediatric Anesthesia, Volume 36, Issue 1, Page 47-56, January 2026.
ABSTRACT Background Preventive measures for postoperative vomiting (POV) in pediatric strabismus surgery are essential. Previous experimental studies have shown the independent antiemetic effects of propofol‐based total intravenous anesthesia (TIVA), dexamethasone (DEX), and ondansetron (OND).
Taiki Kojima, Yusuke Yamauchi, Sayuri Yasuda, Soichiro Obara, Takashi Fujiwara, Aya Sueda   +5 more
wiley   +1 more source

Identifying Red Flags in Myasthenia Gravis Diagnosis, Reassessment, and Myasthenic Crisis: An Italian Delphi‐Based Position Paper

Acta Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background and Purpose Myasthenia gravis (MG) is a complex autoimmune disorder affecting neuromuscular transmission, often leading to diagnostic and therapeutic challenges. Timely identification of “red flags” in diagnosis, therapeutic reassessment, and myasthenic crisis is crucial to optimizing patient outcomes. This Delphi‐based consensus is aimed at
Francesco Habetswallner, Luca Bello, Fiammetta Biasini, Bernardo Maria De Martino, Fiammetta Vanoli, Paolo E. Alboini, Giovanni Antonini, Carlo Antozzi, Valentina Damato, Vincenzo Di Stefano, Amelia Evoli, Matteo Gastaldi, Raffaele Iorio, Michelangelo Maestri, Renato Mantegazza, Roberto Massa, Rita Rinaldi, Francesco Saccà, Carmelo Rodolico, Dominic B. Fee   +19 more
wiley   +1 more source

Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution

Case Reports in Anesthesiology, 2017
Neostigmine has been traditionally used as the agent of choice to reverse Neuromuscular Blockade (NMB) after muscle paralysis during general anesthesia. However, the use of neostigmine has not been without untoward events. Sugammadex is a novel drug that
Michael S. Green, Archana Gundigi Venkatesh, Ranjani Venkataramani   +2 more
doaj   +1 more source

Ketamine versus neostigmine as adjuvants to bupivacaine during ultrasound-guided serratus anterior plane block in modified radical mastectomy. A randomized controlled trial [PDF]

, 2021
Bassant Mohamed Abdelhamid, Samuel Fayez Samy, Ahmed Abdalla Mohamed, Ahmed Samy Saad, Mohamed Ollaek, Abeer Ahmed   +5 more
openalex   +1 more source

Single‐Cell Immune Profiling Reveals Neutrophils Promote Myasthenia Gravis Exacerbation Through BAFF Secretion

Advanced Science, Volume 12, Issue 45, December 4, 2025.
Single‐cell transcriptomics and clinical data show that during myasthenia gravis (MG) exacerbation, bone marrow mature neutrophils expand and enter blood, with parallel increase of B‐cell activating factor (BAFF)–positive neutrophils. Experimental autoimmune myasthenia gravis (EAMG) confirms a pathogenic interferon‐γ (IFN‐γ)–neutrophil–BAFF axis ...
Zhaoxu Zhang, Jingya Dong, Mengyuan Qiu, Jie Bai, Xufeng Cheng, Xiaodong Song   +5 more
wiley   +1 more source

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center

ClinicoEconomics and Outcomes Research, 2016
Michele Carron, Fabio Baratto, Francesco Zarantonello, Carlo Ori Department of Medicine, Anesthesiology and Intensive Care, University of Padova, Padova, Italy Objective: The aim of the study is to evaluate the clinical and economic impact of introducing
Carron M, Baratto F, Zarantonello F, Ori C   +3 more
doaj  

Blunt Pancreatic Transection With Ductal Disruption in a Stable Patient: Rethinking Surgical Necessity Through a Case‐Based Review

Clinical Case Reports, Volume 13, Issue 12, December 2025.
Case‐based review illustrating successful nonoperative management of blunt Grade III pancreatic transection with ductal disruption in a hemodynamically stable patient, highlighting the role of early imaging, multidisciplinary decision‐making, and tailored conservative treatment.
Mehdi Didi, Belkacem Chagar, Ayoub Belhadj, Younes Aissaoui, Youssef Qamouss, Issam Serghini, Said Khallikane   +6 more
wiley   +1 more source

The Use of Parabulbar and Sub‐Tenon Injections to Correct Isolated Resistant Diplopia in Patients With Generalized Myasthenia Gravis: A Long Road to Clinically Meaningful Success

Clinical Case Reports, Volume 13, Issue 12, December 2025.
Changes in ocular alignment following parabulbar betamethasone in myasthenia gravis. Paired images obtained before and after parabulbar betamethasone (0.5 mL per eye; April 22 and May 6, 2025) demonstrate improved horizontal alignment and reduction of vertical deviations in primary gaze, upgaze, right gaze, and left gaze.
M. Marchuk, V. Sanin, V. Mamilov, M. Zinchenko   +3 more
wiley   +1 more source